Gycated Hemoglobin(HbA1c) Determination and Its Utilization for Monitoring Long-Term Glycemic Control of Diabetes Mellitus;Gli̇kozi̇le Hemoglobi̇n(Hba1c) Ölçümü ve Di̇abetes Melli̇tusun Uzun Dönem Gli̇semi̇k Kontrolünde Kullanilmasi

Gulhane Medical Journal

Volumn 45, Issue 4, 2003, Pages 387-395

  Kurt, Ismail ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diabetes Mellitus; Glycated Hemoglobin; HbA1c

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE CONTROL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY DIAGNOSIS; LONG TERM CARE; PATIENT MONITORING; REVIEW; STANDARDIZATION;

EID: 1542284281     PISSN: 13020471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 329: 977-986, 1993.
2. UK Prospective Diabetic Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
3. American Diabetes Association: Tests of glycemia in diabetes. Diabetes Care 26: (Supp 1) S106-S108, 2003.
4. Marshall, S.M., Barth, J.H.: Standardization of HbA1c measurements: a consensus statement. Ann Clin Biochem 37: 45-46, 2000.
5. Lundberg, G.D.: How clinicians should use the diagnostic laboratory in a changing medical word. Clin Chim Acta 280: 3-11, 1999.
6. Plebani, M.: The clinical importance of laboratory reasoning. Clin Chim Acta 280: 35-45, 1999.
7. Service, FJ., Molnar, G.D., Taylor, FT.: Urine glucose analysis during continious blood glucose monitoring. JAMA 222: 294-298, 1972.
8. American Diabetes Association: Self-monitoring of blood glucose (Consensus statement). Dabetes Care 10: 95-99, 1987.
9. Miedema, K.: Monitoring of diabetes mellitus. eJIFC vol 13(5),2002 http://www.ifcc.org/ejifcc/vol13no5/1305200216.htm
10. Jeppsson, J-O., Kobold, U., Ban, J., et al.: Approved IFCC referance method for the measurement of HbA1c in human blood. Clin Chem Lab Med 40: 78-89, 2002.
11. Bunn, H.F.: Nonenzymatic glycosylation of protein: relevance of diabetes. Am J Med 70: 331-338, 1981.
12. Sacks, D.B., Bruns, D.E., Goldstein, D.E., Maclaren, N.K., McDonald, J.M., Parrott, M.: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48: 436-372, 2002.
13. Roth, M.: "Glycated hemoglobin", not "glycosylated" or "glucosylated"(Letter) 29: 1991, 1983.
14. Tahara, Y., Shima, K.: Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 18: 440-447, 1995.
15. Golstein, D.E., Little, R.R., Wiedmeyer, H.M., England, J.D., Mc, Kenzie, E.M.: Glycated hemoglobin: methodologies and clinical applications. Clin Chem 32: 664-670, 1986.
16. US. Food and Drug Administration: FDA clears home glycated hemoglobin for test for diabetes FDA Talk papers (T02-55) December 17, 2002 (http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01182.html
17. Goldstein, D.E., Little, R.R., Lorenz, R.A., Malone, J.I., Nathan, D., Peterson, C.M.: Tests of glycemia in diabetes. Diabetes Care 18: 896-990, 1995.
18. Little, R.R., Rohlfing, C.L., Wiedmeyer, H-M., Myers, G.L., Sacks. D.B., Goldstein. D.E.: The national glycohemoglobin standardization program(NGSP): a five-year progress report. Clin Chem 47: 1985-1992, 2001.
19. Nuttall, F.Q.: Effect of age on the percentage of hemoglobin A1c and the percentage of total glycohemoglobin in non -diabetic persons. J Lab Clin Med 134: 451-453, 1999.
20. Hashimoto, Y., Futamura a, İkushima, M.: Effect of aging on HbA1c in a working male Japanese population. Diabetes Care 18: 1337-1349, 1995.
21. Wiener, K., Roberts, N.B.: Age does not influence levels of HbA1c in normal subject. QJM 2: 169-173, 1999.
22. Tarim, O., Kucukerdoǧan, A., Gunay, U., Eralp, O., Ercan, I.: Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int 41: 357-362, 1999.
23. Nathan, D.M., Francis, T.B., Palmer, J.L.: Effects of aspirin on determination of glycosylated hemoglobin. Clin Chem 29: 466-469, 1983.
24. Stevens, V.J., Fanti, W.j., Newma, C.B., Sims, R.V., Cerami, A., Peterson, C.M.: Acetaldehyde adducts with hemoglobin. J Clin Invest 67: 361-369, 1981.
25. Bry, L., Chen, P.C., Sacks, D.B.: Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 47: 153-163, 2001.
26. Weykamp, C.W., Miedama, K., de Haan, T., Dolemen, C.: Carbamylated hemoglobin interference in glycohemoglobin assays(Letter). Clin Chem 45: 438-440, 1999.
27. National Glycohemoglobin Standardization Program (NGSP): http://www.missouri.edu/~diabetes/ngsp.html.
28. Roberts, W.L., Chiasera, J.M., Ward-Cook, K.M.: Glycohemoglobin results in samples with hemoglobin C or S trait: A comparison of four test systems. Clin Chem 45: 906-908, 1999.
29. Toolis, F., Wortley, L.: Hemoglobinopathy diagnosed on HbA1c analysis. Ann Clin Biochem 40: 194-197, 2003.
30. Rendell, M., Brannan, C., Nierenberg, J., Rasbold, K., Hestorff, T.: Fingerstick glycosylated hemoglobin, plasma protein, and albumin. Diabetes Care 10: 629-632, 1987.
31. Rohlfing, C.L., Wiedmeyer, H.M., Little, R.R., England, D.J., Tennill, A., Goldstein, D.E.: Defining the relatioship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in Diabetes Control and Complications Trial. Diabetes Care 25: 275-278, 2002.
32. Wiener, K.: A falling HbA1c is not necessarily an indicator of improving diabetes control. Ann Clin Biochem 38: 406-407, 2001.
33. American Diabetes Association. Standarts of medical care for patients with diabetes mellitus. Diabetes Care 26: (Supp 1), S35-S50, 2003.
34. Larsen, M.L., Horder, M., Mogensen, E.F.: Effect of long-term monitoring of glycosylated hemoglobin levels in insulin dependent diabetes mellitus. N Eng J Med 323: 1021-1025, 1990.
35. Kilpatrick, E.S., Maylor, P.W., Keevil, B.G.: Biological variation of glycated hemoglobin. Implication for diabetes screning and monitoring. Diabetes Care 21: 261-264, 1998.
36. The Expert Committee on the diagnosis and classification of diabetes mellitus. Report of the expert committee on diagnosis and classification of diabetes mellitus. Diabetes Care 26: (Supp 1) S5-S20, 2003.
37. Tormey, W.P., Hickey, D.P.: An urgent use of hemoglobin A1c? Clin Chem 43: 1463, 1997.
38. Peters, A.L., Davidson, M.B., Schringer, D.L., Hasselblad. V.: A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis research group on the diagnosis of diabetes using glycosylated hemoglobin levels. JAMA 276: 1246-1252, 1996.
39. Goulle, J.P., Lacroix, C., Bouige, D.: Glycated hemoglobin: a Useful post-mortem referance marker in determining diabetes. Forensic Sci Int 128: 44-49, 2002.
40. Kurt, İ., Kutluay. T., Karaca, L.: Klinik Biyokimyada analitik gözden geçirme: Serum glikozile protein ölçüm yöntemleri. Biyokimya Dergisi 18: 109-138, 1993.
41. Frandsen, E.K., Sabagh, T., Bacchus, R.A.: Serum fructosamine in diabetic pregnancy. Clin Chem 34: 316-319, 1988.
42. Beyhan, Z., Çorakçi, A., Arpaci, F., Gündoǧan, M.A., Kurt, İ.: Diabetes mellitusta glisemik kontrolun deǧ erlendirmesinde HbA1c ile fruktozaminin karşilaştirmasi. Türk Diabet Yilliǧi, 7: 133-140, 1988-1989.
43. Yamanouchi, T., Ogata, N., Tagaya, T., Kawasaki, T., Sekino, N., Funato, H., Akaoka, L., Miyashita, H.: Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control. Lancet. 347(9014): 1514-8, 1996.
44. Makita, Z., Radoff, S., Rayfield, E.J., Yang, Z., Skolnik, E., Delaney, V., et al.: Advanced glycosylation end products in patients with diabetic nephropathy. N Eng J Med 325: 836-842, 1991.